<scp>WHO</scp> 2022 landscape of papillary and chromophobe renal cell carcinoma
João Lobo(Universidade do Porto), Holger Moch(University of Basel), Satish K. Tickoo(Unknown), Anthony J. Gill(The University of Sydney), Toyonori Tsuzuki(Aichi Medical University Hospital), Mark A. Rubin(University of Bern), Samra Turajlic(Royal Marsden NHS Foundation Trust), Arndt Hartmann(Universitätsklinikum Erlangen), Éva Compérat(Vienna General Hospital), George J. Netto(University of Pennsylvania), Puay Hoon Tan(Eye & Retina Surgeons), Daniel M. Berney(Queen Mary University of London), Santosh Menon(Homi Bhabha National Institute), Riuko Ohashi(Niigata University), Ming Zhou(Indiana University School of Medicine), Mahul B. Amin(Ontario Institute for Cancer Research), Ian A. Cree(Centre international de recherche sur le cancer), John R. Srigley(University of Toronto), Maria Rosaria Raspollini(Azienda Ospedaliero-Universitaria Careggi)
Cited by 112
Related Papers
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
|Science Translational Medicine|2014|5.1k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
UALCAN: An update to the integrated cancer data analysis platform
|Neoplasia|2022|2.5k
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
|New England Journal of Medicine|2015|2.2k